We’re excited to share highlights from this year’s Association for Vascular Access (AVA) Annual Scientific Meeting ! It was an incredible...

We are excited to announce that our co-founders, Rebecca Stjernberg Bejhed and Christopher Blacker, recently shared some of our latest...

Advancing IV therapy through collaboration: a visit to CHUC hospital

We are proud to share that our COO, Rebecca Stjernberg Bejhed, recently visited one of our partnering hospitals to oversee the progress...

ReLink achieves registered trademark status in India, strengthening global commitment to patient safety

Rebecca Bejhed Returns from NIVAS Conference with Valuable Insights

Interlinked AB has reached a significant milestone with the FDA registration of our innovative solution designed to improve healthcare

As May wraps up, we are thrilled to share some key highlights from an incredibly productive month at Interlinked AB!

Interlinked COO Rebecca Bejhed is back from the Infusion Nurses Society 2024

Interlinked thanks KTH Innovation for their steadfast support from the very beginning.

Interlinked conducted a supplier audit, to ensure our commitment to maintaining the highest standards in our production processes.

Reflecting on LSI - Life Science Intelligence™ USA: A Source of Inspiration and Innovation

Strengthening Our Core: A Successful Collaboration in Cork

Interlinked is engaging with a university closely connected with a leading hospital.

Interlinked is into discussions with our sales collaborators, all focused on introducing ReLink to the Irish market.

Interlinked CEO Katarina Hedbeck shares our transformative journey at Web Summit Qatar

Interlinked is thrilled to reflect on a successful week at Arab Health 2024.

Tada Group's COO Leads Successful Usability Testing for ReLink Device in Linköping

Tada Group Attends Hazardous Drugs Best Practice Nursing Conference in London

Showcasing Innovation at the Swecare Event: ReLink's Impact on Elderly Care in China